We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The UK NSC ethical framework for screening, comprised of 4 broad ethical principles.
We are considering making Colourstart Test 65mcg Cutaneous Patch available to buy without prescription from retail outlets. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about...
Briefing note prepared by the Scientific Pandemic Influenza Group on Behaviours (SPI-B) for the Scientific Advisory Group for Emergencies (SAGE).
When and how to take samples from breeding chickens for the salmonella national control programme (NCP), and what happens if a flock tests positive.
How the government intends to scale up testing programmes to provide a test to anyone who needs one.
First published during the 2019 to 2022 Johnson Conservative government
S75 Screening in relation to Northern Ireland (Ministers, Elections and Petitions of Concern) Bill 2021
Reports presenting annual data for antenatal infection screening In England by regions.
Optional English reading test materials used in May 2024.
These publications explain abdominal aortic aneurysm (AAA) screening and support the NHS AAA screening programme.
Guidance to support NHS antenatal and newborn (ANNB) screening providers and commissioners in addressing inequalities throughout the screening pathway.
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.
An overview of the infectious diseases in pregnancy screening end-to-end pathway.
Guidelines for calculating quantitative image quality parameters for x-ray detectors in breast screening.
Executive summary of quality assurance (QA) visit in Shropshire, Telford and Wrekin held on 21 June 2017.
Information about the NHS population screening programmes available to transgender and non-binary people in England.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).